Provectus Biopharmaceuticals, Inc. announced the reestablishment of the company's Strategic Advisory Board (the SAB). The SAB will comprise business, medical, clinical, and biopharmaceutical industry experience elements. Initial SAB appointees are John W. Jack' Lacey III, M.D., and Ed Pershing as SAB Chairman. Provectus also announced Mr. Pershing was appointed an observer (serving exclusively in an advisory capacity only) of the Company's board of directors, and Bruce Horowitz was retained as Provectus' chief operations consultant. Dr. Lacey was the former Chief Medical Officer and Senior Vice President of University of Tennessee Medical Center. Mr. Pershing has co-founded multiple professional services firms specializing in healthcare related matters. His healthcare experience and expertise includes turnaround/performance improvement initiatives, long-range planning studies, development of numerous hospital and medical office projects, restructuring of healthcare organizations, liaison between boards of directors and management in crafting corporate visions and strategies, mergers, acquisitions, divestitures, and leasing arrangements. Mr. Pershing also has served as an expert witness on healthcare industry matters and in several Certificate of Need appeals, and represented healthcare organizations before regulatory agencies. Mr. Rodrigues added, Ed brings impeccable integrity and accountability across the country back to the Company. As chief operations consultant to Provectus, Mr. Horowitz's responsibilities will include overseeing company operations and the work of executives, managers, and staff members; prioritizing and continuing the Company's search for a Chief Medical Officer and a new Chief Executive Officer; assisting in fundraising activities; and, managing certain partner and vendor relationships. Mr. Rodrigues concluded, Bruce brings much needed leadership to the Company as continue its transition towards executing the new business plan, which includes fortifying the management team.